Healthgrades names Mount Sinai Medical Center one of America's 100 Best Hospitals for cardiac, stroke, and Pulmonary Care and Gastrointestinal Surgery. Oct 27, 2026, 08:00 ET Ranked #1 in Florida for Gastrointestinal Surgery MIAMI BEACH, Fla., Oct. 27, 2026 /PRNewswire/ - Recognized among America's 100 Best Hospitals (Top 2% nationally) for three consecutive years, Mount Sinai Medical Center announced today that it has achieved numerous national accolades for clinical excellence from Healthgrades, the #1 site Americans use when searching for a doctor or hospital. Mount Sinai earned four America's 100 Best Hospitals specialty distinctions - Cardiac Care(TM)(2027), Pulmonary Care(TM)(2026-2027), Stroke Care(TM)(2024-2027), and Gastrointestinal Surgery(TM)(2024-2027) - and ranked among the top 5 in Florida for: * Gastrointestinal Surgery (#1) * Cranial Neurosurgery (#3) * Cardiac Care (#5) * Cardiology Services (#5) * Neurosciences (#5) * Stroke Care (#5) Among Mount Sinai's new recognitions are nine Specialty Excellence Awards spanning cardiac, neurosciences, pulmonary, gastrointestinal and critical care. The medical center ranks among the top 5% nationwide for cardiology services, neurosciences, cranial neurosurgery, treatment of stroke, overall pulmonary services and gastrointestinal surgery. Mount Sinai also achieved 15 Five-Star Ratings across high-impact procedures and conditions. Several ratings reflect more than a decade of consistent performance. Mount Sinai has been a five-star recipient for treatment of gastrointestinal bleed for 11 consecutive years, and for stroke and sepsis for 10. "Being ranked first in Florida for gastrointestinal surgery, and recognized nationally across cardiac, pulmonary and stroke care, tells our community that the outcomes here stand with the best in the nation," said Gino R. Santorio, President and CEO of Mount Sinai Medical Center. "These results belong to our physicians, nurses and care teams, who deliver them one patient at a time, year after year." Mount Sinai's achievements are based solely on what matters most: patient outcomes. Unlike rankings based on surveys or reputation, Healthgrades evaluates hospital performance strictly on objective clinical outcomes, risk-adjusted mortality and complication rates, across more than 30 common conditions and procedures at approximately 4,500 hospitals nationwide. The impact of choosing a high-performing hospital is significant. Healthgrades' 2027 analysis revealed that if all hospitals performed at the level of five-star rated facilities during the 2023-2025 study period, 227,229 lives could have been saved and 158,138 complications could have been avoided.* "Finding a hospital that excels in a given procedure or treatment can transform a patient's health trajectory," said Alana Biggers, MD, MPH, medical advisor at Healthgrades. "We're proud to recognize Mount Sinai Medical Center for its top-tier performance in cardiac, pulmonary, stroke and gastrointestinal surgery, and commend its team for delivering exceptional patient outcomes when it matters most." Patients and community members can visit Healthgrades' Specialty Excellence Patient Advocate Center to learn more about how Healthgrades identifies the top-performing hospitals for specialty care. *Statistical averages based on Healthgrades' analysis of MedPAR data for years 2023 through 2025 and represent three-year estimates for Medicare patients only. About Mount Sinai Medical Center Founded in 1949, Mount Sinai Medical Center is the largest independent, private, not-for-profit teaching hospital in South Florida. Mount Sinai's mission is to provide quality health care to a diverse community enhanced through teaching, research, charity care, and financial responsibility. Mount Sinai's Centers of Excellence combine technology, research, and academics to provide innovative and comprehensive care in cardiology, neuroscience, oncology, urology, and orthopedics. One of the original statutory teaching hospitals in the state of Florida, Mount Sinai is the hospital of choice for those who seek the level of expertise and care that only a teaching hospital can offer. Mount Sinai currently offers ten convenient locations in Miami-Dade County, including four emergency centers, and five specialty care offices in Monroe County. About Healthgrades Healthgrades is dedicated to empowering meaningful connections between patients, doctors, and hospitals. As the #1 platform for finding a doctor and a leader in healthcare transparency, we help millions of consumers each month find and schedule appointments with their healthcare professional of choice and prepare for their appointments with best-in-class, treatment-focused content. For over 20 years, our health system, group practice, and life sciences marketing solutions have helped our partners reach and engage consumers on their way to the doctor. SOURCE Mount Sinai Medical Center

Carlos A. Gimenez highlights healthcare expansion and Venezuelan democracy efforts on social media. On September 26, Rep. Carlos A. Gimenez used social media to mark the opening of Mount Sinai Medical Center in Westchester and voice support for democratic reforms in Venezuela. 11h ago Saturday, Sept 26 By K. C. Mendez Rep. Carlos A. Gimenez, a U.S. Congressman representing Florida's 28th district since 2021, posted a series of messages on September 26, 2026, highlighting both local healthcare developments and his stance on political issues in Venezuela. Gimenez has represented Florida's 28th District since defeating Debbie Mucarsel-Powell in 2021 and previously served in both the Florida House of Representatives and Miami-Dade County Commission from 2005 to 2011. Born in Havana in 1954 and currently residing in Miami, he graduated from Barry University with a BPA in 1999.

UF-led Alzheimer's research center awarded $22 million grant. September 16, 2026 As scientists edge closer to changing the lives of people with dementia by finding ways to diagnose it earlier and treat it more effectively, a University of Florida-led research network has been awarded a new $22.3 million, five-year grant to propel these discoveries into clinical practice. The National Institute on Aging has renewed a grant for the 1Florida Alzheimer's Disease Research Center, or 1Florida ADRC, which uses the newest techniques to evaluate people with and without memory disorders and other thinking problems in research studies as part of the nationwide network of Alzheimer's Disease Research Centers. "We've reached a transformative time in Alzheimer's research, where not only are we advancing potential disease-modifying therapies, but very soon it may be possible for people to go to their primary care provider and get a blood test before they even have any symptoms," said Glenn Smith, Ph.D., a professor in the UF College of Public Health and Health Professions' Department of Clinical and Health Psychology who co-leads the 1Florida ADRC. "This new federal investment will enable us to continue our vital community-engaged research, which is a catalyst for state and national improvements in public health," he said. A collaboration of UF, Mount Sinai Medical Center in Miami Beach, the University of Miami, Florida Atlantic University and Florida International University, the consortium also includes health systems and community partners, with a shared goal of expanding access to clinical trials and improving care across the state. Over 580,000 Florida residents, or 12.5%, are currently estimated to have Alzheimer's, according to the latest figures from the Alzheimer's Association, and with population growth, the number of cases is expected to double by 2050. Many more thousands suffer from related forms of dementia, such as Lewy body dementia, which is also a focus of study at the 1Florida ADRC. Since its launch in 2015, the 1Florida ADRC has contributed to over 410 scientific papers. Among them is a groundbreaking method to detect brain changes associated with Alzheimer's risk prior to clinical signs, using a type of MRI known as "free-water" imaging to reveal subtle abnormalities in brain microstructures. That study was led by David Vaillancourt, Ph.D., chair of the UF College of Health and Human Performance's Department of Applied Physiology and Kinesiology and principal investigator of the 1Florida ADRC biomarker and neuroimaging component. Next up, the new federal funding will be combined with state resources such as the Ed and Ethel Moore Alzheimer's Disease Research Program to accomplish many goals, said Melissa Armstrong, M.D., a professor in the UF College of Medicine's Department of Neurology and principal investigator of the 1Florida ADRC clinical component, which has followed over 1,000 volunteer participants with and without memory disorders, as well as family members. "The 1Florida ADRC is a statewide hub," said Armstrong, a national leader in studying patient preferences, decision-making and caregiving needs for people with dementia. "We partner with many other research studies. Some researchers are drawing data from the 1Florida ADRC repository; some will use our data to answer a new research question. Sometimes they're looking for eligible research participants." Twenty-four active studies rely on the 1Florida ADRC for data, specimens, expertise and participant referral, fueling research efforts at UF's McKnight Brain Institute and the Norman Fixel Institute for Neurological Diseases at UF Health. Moreover, the 1Florida ADRC provides pilot grants to early-career investigators to build the next generation of scientists in Alzheimer's and related dementias. With the new federal funding, this work will continue at a crucial juncture for the field. "Thanks to the support and advocacy of the Florida Congressional delegation, the 1Florida ADRC will continue our unique capabilities in computing power and artificial intelligence, advanced neuroimaging, genomics, neuropsychology and neuropathology," Smith said. Related topics. For the media. Media contact. Peyton Wesner Communications Manager for UF Health External Communications